US States Enact E-Cigarette Bans, PMTA Registry Bills Trigger Controversy

Regulations by 2FIRSTS, edited by Sophia
May.06.2024
US States Enact E-Cigarette Bans, PMTA Registry Bills Trigger Controversy
Virginia bans flavored e-cigarettes, Iowa still undecided. Critics argue laws harm smoking cessation options. Major economic impact expected.

According to overseas media FilterMag, on May 2nd, it was reported that flavored e-cigarettes will be banned in the state of Virginia, but the ban will not take effect until one year later. Meanwhile, the decision on similar legislation in Iowa is pending the governor's signature or veto. These are just the latest PMTA registration laws, which are increasingly spreading across the United States under the guise of protecting consumers from unregulated products. Critics argue that these laws harmfully restrict people's options for quitting smoking.

 

Iowa Governor Kim Reynolds has not indicated whether she will sign a bill passed by the legislature in April. The Consumer Advocates for Smoke-free Alternatives Association (CASAA) has dubbed it the "Big Tobacco Protection Act." In Virginia, lawmakers also recently passed a registration bill, which Governor Glenn Youngkin (R) approved but with an amendment to delay implementation until July 1, 2025. The bill was passed by the legislature in April.

 

Oklahoma, Louisiana, and Alabama have implemented the PMTA registration legislation, according to Ecigator reports. While laws in Kentucky, Utah, and Wisconsin are set to take effect by 2025 (though there is ongoing litigation against the legislation in Kentucky), a report states that "legislators in about 20 other states are currently considering similar bills.)

 

According to advocates for harm reduction in tobacco, banning flavored e-cigarettes will only lead consumers to turn to the illegal market or even revert back to traditional cigarettes. Research also indicates that the choice of flavors is highly important for individuals transitioning from cigarettes to e-cigarettes.

 

However, tobacco companies that are actively promoting the above-mentioned legislation have a different perspective on this. They believe that these laws will help combat the illicit tobacco market and ensure that all kinds of businesses accept products authorized by the U.S. Food and Drug Administration (FDA).

 

Critics of these bills argue that small businesses and individuals trying to quit smoking will suffer. More than 1,800 people in Virginia could lose their jobs, and the state could lose over $250 million in economic benefits. Small businesses will also face fines of $1,000 per day for each unapproved product they sell. While tobacco giants are advocating for the ban, the public is skeptical of their motives.

 

Most legislators do not understand that the purpose of the PMTA registration is to ban the sale of the majority of e-cigarette products intended for use by adults in this state.

 

The FDA is facing harsh criticism from tobacco harm reduction advocates for denying millions of PMTA applications. They argue that the barriers to submission are so high that only the largest companies with significant financial and scientific resources have a chance at authorization.

 

However, one of the sponsors of the legislation, Virginia Delegate Rodney Willett (D-Henrico), said that despite the lengthy challenge, the FDA's program is important because a large number of e-cigarette products from China are flooding in, which he referred to as being "largely unregulated and untaxed in most cases." Willett believes, "Most legislators do not understand that the purpose of PMTA registration is to ban the sale of the vast majority of e-cigarette products used by adults in this state." "They think they are fighting against villains from China, but in reality, they are making the lives of their own constituents worse."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Russia has placed shares in four Japan Tobacco International businesses under temporary management, the first such move involving a major global tobacco manufacturer, according to Interfax. JTI held 35.8% of Russia's tobacco market by volume in the first nine months of 2026. While British American Tobacco and Imperial Brands have exited Russia, Philip Morris International continues operating there. As the market changes and diplomatic efforts continue, could international tobacco companies that left Russia eventually return?
Nov.06
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden is expected to oppose a European Union proposal to raise minimum tobacco excise duties, Law360 reported on October 26, 2026, citing an EU official. A provisional Council agenda dated October 23 confirms that the tobacco taxation package is scheduled for discussion at the November 9 finance ministers' meeting, where member states will seek a general approach. The proposed reforms would raise minimum taxes on conventional tobacco products and establish EU-wide excise rules for vaping liquids, heated tobacco and nicotine pouches. Sweden supports harmonising tobacco taxation rules but objects to requiring nicotine pouches to bear the same minimum tax burden as certain smoking tobacco products. As EU indirect tax legislation requires unanimous Council approval, Swedish opposition could block the proposal in its current form.
Regulations
Oct.29
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City's Department of Consumer and Worker Protection (DCWP) opened applications on November 2, 2026, for a lottery covering tobacco and electronic cigarette retail dealer licenses, with a deadline of 5 p.m. New York local time on November 30. According to the city's October 1 notice, 55 electronic cigarette retail license slots are available across 23 community districts, including 28 in Brooklyn, alongside 322 tobacco retail license slots across 41 districts. Businesses must enter the lottery and, if invited, complete licensing requirements within 65 days. New York City continues to restrict e-cigarette retail sales to tobacco-flavored or unflavored products, while city retail licenses do not replace FDA product marketing authorization.
Market
Nov.04